These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Issues in making a therapeutic choice: recombinant and/or human-derived products. Aledort LM. Haemophilia; 2001 Jan; 7(1):89-90. PubMed ID: 11136386 [No Abstract] [Full Text] [Related]
10. A comparison of the treatment of patients with factor IX deficiency to that of those with factor VIII deficiency: results of an International Survey conducted as part of the International FIX Treatment Network. Berntorp E, Shapiro AD, Waters J, Astermark J. Haemophilia; 2014 Sep; 20(5):e362-4. PubMed ID: 25156443 [No Abstract] [Full Text] [Related]
15. Blood and neoplastic diseases. Haemophilia and related disorders. Rizza CR. Br Med J; 1974 Oct 05; 4(5935):36-8. PubMed ID: 4547674 [No Abstract] [Full Text] [Related]
16. Prophylaxis in children with haemophilia - the Polish experience. Klukowska A, Urasinski T, Janik-Moszant A, Bobrowska H, Balwierz W, Woznica-Karczmarz I, Dobaczewski G, Wlazlowski M, Koltan A, Badowska W, Dakowicz L, Karolczyk G, Kostrzewska M, Korczowski B, Wasinski D, Pietrys D, Laguna P, Wysocka M. Haemophilia; 2014 Jan 05; 20(1):e108-10. PubMed ID: 24251651 [No Abstract] [Full Text] [Related]
18. The evolution of recombinant factor replacement for hemophilia. Sankar AD, Weyand AC, Pipe SW. Transfus Apher Sci; 2019 Oct 05; 58(5):596-600. PubMed ID: 31421983 [Abstract] [Full Text] [Related]
19. Production of antihemophilic factor in France. Allain JP. Scand J Haematol Suppl; 1984 Oct 05; 40():499-503. PubMed ID: 6433471 [No Abstract] [Full Text] [Related]